Finally, a global approach to precision GI care.

We’re on a mission to bring world-class care and treatment to patients around the world. Advances in machine learning and artificial intelligence are helping us create a complete GI ecosystem with the power to turn this vision into reality.

AI and ML: driving the future of therapeutic GI care.

The level of precision we’re now introducing to GI care would have been unimaginable just a generation ago. As our name implies, success in this endeavor requires consistently building on a series of incremental advances. In this, our mission is clear.

Thought leadership in action.

It’s enormously gratifying to see our pioneering work highlighted as the cover feature of the September 2022 issue of Gastroenterology, the official journal of the AGA Institute. The Iterative Health team continues to grow by attracting many of the preeminent minds in our field.

Powering research.
Empowering physicians.

Iterative Health now makes it possible for practicing physicians to integrate and strengthen clinical research in their practices as a sustainable ancillary service.


  1. Achieve greater efficiencies in clinical trial enrollment.
  2. Increase patient access to quality care and novel therapeutics.
  3. Create an ancillary profit center to support other aspects of a practice.


  1. Accelerate clinical trials by automating the patient recruitment process.
  2. Reduce costs and time spent identifying and screening patients.
  3. Assess a broader base of sites with clinical research capabilities.

Clinical trial recruiting reimagined.

The process of pre-screening patients for clinical trial eligibility has always been a challenge. Our proprietary algorithms leverage machine learning, along with powerful computer-enhanced analysis. This helps eliminate recruitment bottlenecks, speeding the process of bringing new drugs and therapies to market.

US Spending


Each year in the U.S. we spend $20B on colon cancer screenings,2a 2b but endoscopists using traditional methodology still miss up to 26% of all adenomas.2c We know that significantly better detection rates are now within reach.



Our AI-enhanced approach will significantly improve adenoma detection.3 This will translate to better care for millions of patients around the world.


A scalable, more equitable approach to GI care.

AI-enabled documentation technology has the potential to improve both quality and continuity of patient care. With standardized, high-quality reporting across institutions, this same high standard of care can finally become a reality for previously underserved populations.